Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial

Circulation: Cardiovascular Interventions

Volumn 3, Issue 3, 2010, Pages 267-276

  Laird, John R ^a   Katzen, Barry T ^b   Scheinert, Dierk ^c   Lammer, Johannes ^d   Carpenter, Jeffrey ^e   Buchbinder, Maurice ^f   Dave, Rajesh ^g   Ansel, Gary ^h   Lansky, Alexandra ⁱ   Cristea, Ecaterina ⁱ   Collins, Tyrone J ^j   Goldstein, Jeffrey ^k   Jaff, Michael R ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Baptist Heart and Vascular Center   (United States)

^c UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f SCRIPPS CLINIC   (United States)

^g Pinnacle Health System   (United States)

^h Riverside Hospital   (United States)

ⁱ CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^j Oschner Clinic Foundation   (United States)

^k Prairie Education and Research Cooperative   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Angioplasty; Peripheral vascular disease; Stents

Indexed keywords

NITINOL;

ADULT; AGED; ANGIOPLASTY; ARTERY OCCLUSION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; ECHOGRAPHY; FEMALE; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; ALLOYS; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; DRUG-ELUTING STENTS; EUROPE; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UNITED STATES;

EID: 77955881516     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.109.903468     Document Type: Article

References (33)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1-S70.
2. Capek P, Mclean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991;83(suppl): I70-I80.
3. Surowiec SM, Davies MG, Eberly SE, Rhodes JM, Illig KA, Shortell CK, Lee DE, Waldman DL, Green RM. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg. 2005;41:269-278.
4. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Cath Cardiovasc Interv. 2007;69:910-919.
5. Jeans WD, Armstrong S, Cole SEA, Horrocks M, Baird RN. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology. 1990;177:559-564.
6. Saxon RS, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311.
7. Murray RR Jr, Hewes RC, White RI Jr, Mitchell SE, Auster M, Chang R, Kadir S, Kinnison ML, Kaufman SL. Long-segment femoropopliteal stenoses: is angioplasty a boon or a bust? Radiology. 1987;162:473-476.
8. Hews RC, White RI Jr, Murray RR, Kaufman SL, Chang R, Kadir S, Kinnison ML, Mitchell SE, Auster M. Long-term results of superficial artery angioplasty. AJR Am J Roentgenol. 1986;146:1025-1029.
9. Muradin GSR, Bosch JL, Stijnen T, Hunink MGM. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: metaanalysis. Radiology. 2001;221:137-145.
10. Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of longsegment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg. 1997;25:74-83.
11. Do DD, Triller J, Walpth BH, Stirnemann P, Mahler F. A comparison study of self-expanding stents vs. balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol. 1992;15: 306-312.
12. Abahji TN, Tató F, Rieger J, Öffner A, Will S, Hoelscher G, Weiss N, Hoffmann U. Stenting of the superficial femoral artery after suboptimal balloon angioplasty: one-year results. Int Angiol. 2006;25:184-189.
13. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, Lammer J. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
14. Grimm J, Müller-Hülsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001; 12:935-941.
15. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg. 2003;37:487-494.
16. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, van de Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopleal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
17. Mewissen MW. Stenting in the femoropopliteal arterial segment. Tech Vasc Interv Radiol. 2005;8:146-149.
18. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Bérégi JP. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106: 1505-1509.
19. Duda SH, Bosiers M, Lammer J, Scheinert D, Zellar T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielmans H, Bérégi JP. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338.
20. Duda SH, Bosiers M, Lammer J, Scheinert D, Zellar T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielmans H, Bérégi JP. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13: 701-710.
21. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
22. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit a 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749.
23. Krankenberg H, Schluter M, Steinkamp H, Burgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tubler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116: 285-292.
24. Schlager O, Dick P, Sabeti S, Amighi J, Miekusch W, Minar E, Schillinger M. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005;12:676-684.
25. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus eluting stent implantation. Am J Cardiol. 2009;103: 923-929.
26. Hewes RC, White RI Jr, Murray RR, Kaufman SL, Chang R, Kadir S, Kinnison ML, Mitchell SE, Auster M. Long-term results of superficial femoral artery angioplasty. AJR Am J Roentgenol. 1986;145:1025-1029.
27. Ahmadi R, Ugurluoglu A, Schillinger M, Katzenschlager R, Sabeti S, Minar E. Duplex ultrasound-guided femoropopliteal: initial and 12-month results from a case controlled study. J Endovasc Ther. 2002;9:873-881.
28. Jämsén TS, Manninen HI, Jaakkola PA, Matsi PJ. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology. 2002;225:345-352.
29. Schillinger M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Minar E. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther. 2003;10:288-297.
30. Nikanorov A, Smouse HB, Osman K, Bialas M, Shrivastava S, Schwartz LB. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg. 2008;48: 435-440.
31. Scheinert D, Scheinert S, Sax J, Piokowski C, Braunlich S, Ulrich M, Biamino G, Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315.
32. Ranke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander K. Color and conventional image-directed Doppler ultrasonography: accuracy and sources of error in quantitative blood flow measurements. J Clin Ultrasound. 1992;20:187-193.
33. Schlager O, Francesconi M, Haumer M, Dick P, Sabeti S, Amighi J, Mlekusch W, Koppensteiner R, Minar E, Schillinger M. Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a "real world" setting. J Endovasc Ther. 2007;14: 452-459.